Cholesterol medication, Fenofibrate, could reduce SARS-CoV-2 infection by up to 70 per cent: UK study
by Press Release from Outbreak News Today on (#5NBBN)
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in the laboratory by an international collaboration of researchers. The research team, led by the University of Birmingham and Keele University in the [...]
The post Cholesterol medication, Fenofibrate, could reduce SARS-CoV-2 infection by up to 70 per cent: UK study appeared first on Outbreak News Today.